SML Mahindra Ltd., incorporated in the year 1983, is a Small Cap company (having a market cap of Rs 4,393.01 Crore) operating in Auto sector. SML Mahindra Ltd. key Products/Revenue Segments include ...

Abstract: The deployment of Ka-band radar necessitates addressing increased losses due to rain and free-space propagation, in addition to achieving low sidelobe levels (SLL). Substrate integrated ...

SML Group has sold its Clarity software business to Omegro, a buy-and-grow acquirer of software companies. A global RFID and retail technology solutions company, the sale move marks the next phase of ...

This was revealed in the Crime in India 2023 report released by the National Crime Records Bureau . According to the report, the state registered 1,899 cases in 2023, compared to 1,592 in 2022 and ...

SML Limited, a leading innovator with more than five decades of proven expertise in making differentiated and patented platform formulation technologies in crop protection and crop nutrition for ...

Overall survival data are immature but trending in favor of pirtobrutinib, with full analysis expected in 2026. Pirtobrutinib therapy resulted in a clinically meaningful and statistically significant ...

The 33rd annual Antique and Classic Boat Society (ACBS) Smith Mountain Lake chapter Boat Show was held on Sept. 13th at Goodhue Boat Company, Blackwater. Organizers said this year's show set record ...

Private equity firms FountainVest Partners and CPE are nearing an agreement to jointly buy SML Group Ltd. in a deal that could value the RFID and brand identification provider at more than $600 ...

Aster Chemicals & Energy Pte. Ltd., a Singapore-headquartered provider of energy, chemical, and infrastructure solutions in Southeast Asia, has closed a sustainability-linked syndicated term loan ...

Jaypirca significantly improves progression-free survival in treatment-naïve CLL/SLL patients compared to bendamustine plus rituximab. Overall survival trends favorably for Jaypirca, although data is ...

Pfizer veteran Suneet Varma has found his next role. Months after leaving the Big Pharma, Varma has taken the CEO position at the newly created inflammation and immunology startup Intent Biologics.

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...